University of Michigan Kellogg Eye Center

01/20/2026

Glaucoma is a group of eye diseases which cause loss of sight by damaging the optic nerve.

Because there are often no early symptoms, half of people with glaucoma do not know they have the eye disease.

Although there is no cure, early detection and treatment may prevent or delay permanent vision loss.

Learn more: https://michmed.org/3G2K4.

01/13/2026

It started out as a collection of unusual symptoms, including childhood glaucoma, skin rashes, arthritis and spontaneous tendon rupture. Soon, it became a collaborative effort between the Gibson family, doctors, researchers and the NIH to understand a rare type of genetic glaucoma.

A large group of researchers, led by University of Michigan and partnering with University of Missouri, have now received an NIH grant to better understand the disease, its interactions with viral infections, and to develop therapies.

Learn more: https://michmed.org/Q9YQw.

01/12/2026

Dysfunctional cell barriers can cause a range of diseases, including stroke, brain tumors and blinding eye diseases such as diabetic retinopathy.

University of Michigan researchers have uncovered the role of occludin, a protein that regulates the tight connections between cells. They are now working on trying to restore these cell barriers in patients with diabetes, helping them with their vision.

Learn more: https://michmed.org/YWzM4.

01/07/2026

Older adults with severe vision loss are three to four times more likely to fall when they live in homes with hazards such as missing grab bars, tripping risks or broken flooring.

A new study finds that it’s not just that poor vision increases fall risk or that hazards increase fall risk—it’s the interaction between the two that really matters.

Learn more: https://michmed.org/vQqyD.

01/01/2026

Highlights of the year – Woman’s World

Helping patients make confident, informed decisions was a major theme of 2025.

In Woman's World, Christopher Hood, M.D., broke down the risks and benefits of laser eye surgery - especially for women over 45 - while highlighting smart, personalized options for vision correction later in life:

Don’t qualify for LASIK? Discover two alternatives that can improve your vision

12/31/2025

Highlights of the year – TIME

Earlier in 2025, TIME turned to Shahzad Mian, M.D., to answer a common question: Are daily contact lenses better than monthlies?

Dr. Mian shared clear, practical guidance to help people choose the option that best fits their eyes, lifestyle, and long-term vision health:

Eye doctors have a unanimous answer.

12/30/2025

Highlights of the year – Scientific American

Dr. Joshua Ong, was featured in Scientific American explaining how eye and vision changes during long-duration spaceflight could complicate the NASA - National Aeronautics and Space Administration’s plans for future Mars missions.

A powerful example of how vision science at Kellogg informs innovation on a global (and interplanetary) scale:

A mysterious neuro-ocular syndrome remains an unknown risk for long-term spaceflight

12/29/2025

As the year comes to a close, we’re celebrating some of our biggest stories of 2025 and the impact of our Kellogg Eye Center experts.

Our most-read Health Lab article of the year tackled a big question for patients everywhere: Pros and cons of LASIK: Are the risks worth the cost?

This February piece helped readers make informed decisions about laser vision correction by breaking down benefits, risks, and long-term considerations:

Deciding to get LASIK surgery requires thought and evaluation. Here’s what a Michigan Medicine ophthalmologist tells prospective recipients.

12/11/2025

Since 2016, Michael Budd’s vision progressively became worse, regardless of how many eyeglass prescription changes he went through. His vision was blurry and everything looked distorted, especially in the evenings.

He was diagnosed with Fuchs’ dystrophy, a condition where the corneal cells that are responsible for pumping out fluid gradually die off. After treatment at Kellogg with Dr. Mian, his vision has been completely restored.

Read more: https://michmed.org/YWnXe.

12/04/2025

Congratulations, Dr. Rao!

RPB congratulates multi-RPB awardee, Rajesh Rao, MD, of the University of Michigan, for the publication of research on how RNA modifications control how stem cells develop into retinal cells. Read more here: https://bit.ly/4nM0wje

12/02/2025

It’s Giving Tuesday — a day to come together to make a real impact!

Join us in supporting a project that helps people feel better, live longer, and make the most of life: ➡️ Vision Screening for Those in Need.

Your gift matters more than ever. Click to learn more and give today! 💙💛 https://victors.us/givingtuesday2025

11/28/2025

Frances Valentine, co-founded by Elyce Arons, has teamed up with the Mary Tyler Moore Vision Initiative—led by Dr. S. Robert Levine, Mary’s husband—for a Fall 2026 capsule collection paying tribute to the legendary actress and advocate. Drawing inspiration from Mary Tyler Moore’s groundbreaking TV roles, the collection captures her bold sense of style, optimism, and effortless confidence that set trends throughout the 1960s and 1970s.

A portion of the proceeds supports the Vision Initiative’s mission to advance research in preventing and restoring vision loss from diabetes, honoring, and continuing the tireless advocacy championed by Mary Tyler Moore and carried forward by Dr. S. Robert Levine.

Kellogg Eye Center remains a key participant at the Vision Initiative symposium, where a community of experts and leaders unite to accelerate progress against vision loss caused by diabetes.